SCLN
Sciclone Pharmaceuticals Inc
SCLN
SCLN
Delisted
SCLN was delisted on the 13th of October, 2017.
130 hedge funds and large institutions have $316M invested in Sciclone Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
52% less capital invested
Capital invested by funds: $652M → $316M (-$336M)
Holders
130
Holding in Top 10
1
Calls
$247K
Puts
$47K
Top Buyers
| 1 | +$2.74M | |
| 2 | +$2.24M | |
| 3 | +$2.14M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.64M |
| 5 |
SI
Sensato Investors
San Francisco,
California
|
+$1.52M |
Top Sellers
| 1 | -$351M | |
| 2 | -$2.81M | |
| 3 | -$2.7M | |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$2.11M |
| 5 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$1.85M |